Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / SPONSORED ADR
-
Total 13F shares
-
7,932,677
-
Share change
-
+220,914
-
Total reported value
-
$7,299,000
-
Price per share
-
$0.92
-
Number of holders
-
22
-
Value change
-
+$183,711
-
Number of buys
-
9
-
Number of sells
-
6
Institutional Holders of BIOLINERX LTD - SPONSORED ADR (BLRX) as of Q4 2016
As of 31 Dec 2016,
BIOLINERX LTD - SPONSORED ADR (BLRX) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,932,677 shares.
The largest 10 holders included
Senvest Management, LLC, ORBIMED ADVISORS LLC, Alyeska Investment Group, L.P., MORGAN STANLEY, Opaleye Management Inc., DEUTSCHE BANK AG\, MENTA CAPITAL LLC, Commonwealth Equity Services, Inc, NEXT Financial Group, Inc, and Benchmark Capital Advisors.
This page lists
22
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.